Lexaria BioscienceLEXX -3.61%28 Median PS Value is $1.69 as of Jun. 25, 2026, which is 312% above its 10-year median of 0.41. GuruFocus rates LEXX with a GF Score™ of 28/100 and a GF Value™ of $0.75 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 277 Biotechnology companies, Lexaria Bioscience ranks better than 78.7% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Lexaria Bioscience's Median PS Value or its related term are showing as below:
LEXX'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22 Med: 0.41 Max: 0.95
Current: 0.32
During the past 13 years, the highest Price to Median PS Value of Lexaria Bioscience was 0.95. The lowest was 0.22. And the median was 0.41.
LEXX's Price-to-Median-PS-Value is ranked better than 78.7% of 277
companies
in the Biotechnology industry
Industry Median: 0.63
vs LEXX: 0.32
Lexaria Bioscience (NAS:LEXX) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Lexaria Bioscience's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.542
/
1.69
=
0.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lexaria Bioscience Median PS Value Related Terms
Lexaria Bioscience Median PS Value Historical Data
* Premium members only.
The historical data trend for Lexaria Bioscience's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LEXX vs MBRX, ICU, INTI: Median PS Value Comparison
For the Biotechnology subindustry, Lexaria Bioscience's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lexaria Bioscience Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lexaria Bioscience's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Lexaria Bioscience's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 84.5.
Lexaria Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lexaria Bioscience (LEXX) has a Median PS Value of $1.69 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Lexaria Bioscience and its competitors. This is 312% above median its historical median of 0.41. Over the past decade, Lexaria Bioscience's Median PS Value has ranged from 0.22 to 0.95. According to the industry distribution chart, Lexaria Bioscience ranks #59 out of 277 companies in the Biotechnology industry, placing it in the top 21.3%.
Is Lexaria Bioscience's Median PS Value too high?
Lexaria Bioscience's current Median PS Value of $1.69 is 312% above median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 0.95. The Biotechnology industry median Median PS Value is 0.63. Lexaria Bioscience's value of $1.69 is 168.3% above this industry median. Based on the distribution chart, Lexaria Bioscience ranks #59 out of 277 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Lexaria Bioscience has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lexaria Bioscience's Median PS Value compare to MBRX and ICU?
According to the Biotechnology industry distribution chart, Lexaria Bioscience ranks #59 out of 277 companies for Median PS Value. This places Lexaria Bioscience in the top 21% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.63. Lexaria Bioscience's value of $1.69 is 168.3% above this benchmark. Historically, Lexaria Bioscience's own Median PS Value has ranged from 0.22 to 0.95 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.63, Lexaria Bioscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lexaria Bioscience's current Median PS Value of $1.69 is 168.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Lexaria Bioscience and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lexaria Bioscience's current Median PS Value is $1.69, which is 312% above median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lexaria Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Lexaria Bioscience (LEXX) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.75, compared to a current price of $0.54 — trading 27.7% below its estimated fair value. The current Median PS Value is $1.69, which is 312% above median its 10-year median of 0.41 and 168.3% above the Biotechnology industry median of 0.63. Lexaria Bioscience's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Lexaria Bioscience (LEXX), the current Median PS Value is $1.69 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lexaria Bioscience (LEXX) Overvalued in 2026?
Based on GuruFocus' analysis, Lexaria Bioscience stock appears to be undervalued.
The current stock price of $0.54 is trading 27.7% below its estimated GF Value™ of $0.75.
GuruFocus considers Lexaria Bioscience to be Modestly Undervalued.
Key valuation signals for LEXX:
Median PS Value: $1.69 (312% above median its 10-year median of 0.41)
GF Value™: $0.75 vs. price of $0.54 (27.7% below fair value)
Industry Position: 168.3% above the Biotechnology median (#59 of 277)
No single metric tells the full story. See the LEXX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
28GF Score
Get the complete analysis for LEXX
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEXX has been successfully added to your 
